International Journal of Women's Health and Reproduction Sciences

Home Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Jul 2015, Vol 3, Issue 3

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

COPE: Reviewers

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Case Report
Desquamative Inflammatory Vaginitis: The Unknown
María Trinidad Alumbreros Andújar¹, Ana González López¹, Celia Pérez Parra¹, Rafael López Pérez², Carmen Céspedes Casas¹, María Mercedes Ramírez Gómez¹, Castor Martin Francisco¹, Francisco Javier Haya Palazuelos¹
¹Department of Obstetrics and Gynecology, Hospital General University of Ciudad Real, Ciudad Real, Spain ²Department of Pathology, Hospital General University of Ciudad Real, Ciudad Real, Spain
IJWHR 2015; 3: 171?173 DOI: 10.15296/ijwhr.2015.36 Viewed : 3968 times Downloaded : 4924 times. Keywords : Dyspareunia, Inflammation, Vaginitis
Full Text(PDF) \| Related Articles
Abstract

Introduction: Desquamative inflammatory vaginitis (DIV) is a chronic inflammatory process of unknown etiology, characterized by genital pain and profuse vaginal discharge, mainly affecting perimenopausal women. It is an entity little known by clinicians, leading to a delay in diagnosis and the consequent alteration of the patients? quality of life. The aim in this manuscript is to analyze DIV through the review of a case and the scientific literature. Case presentation: We report the case of a 40-year-old woman who presented this clinical profile for several years, being misdiagnosed as more common syndromes such as infectious vaginitis and vaginismus. Finally, after the diagnosis of DIV and the establishment of the specific treatment, she showed a clear symptomatic improvement. Conclusion: The prevalence of DIV is unknown and underestimated, and may affect 8% of women with vulvovaginal symptoms. To reach the correct diagnosis, it is required to observe a few simple clinical and laboratory criteria defined by Sobel in 1994. It responds to the topical therapy with clindamycin or hydrocortisone in 95% of cases, but in most cases a long-term maintenance therapy is necessary to control the symptoms.